NCT06703138

Brief Summary

Bone marrow lesions are common, and imaging findings are associated with various aetiologies, as compared to conventional radiography and computed tomography (CT), MRI is a better non-invasive imaging modality to evaluate vertebral bone marrow, due to better soft-tissue contrast, so the aim of our study is the use of MRI diffusion in differentiating various vertebral bone marrow pathological lesions.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 21, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 25, 2024

Completed
20 days until next milestone

Study Start

First participant enrolled

December 15, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

November 29, 2024

Status Verified

November 1, 2024

Enrollment Period

12 months

First QC Date

November 21, 2024

Last Update Submit

November 26, 2024

Conditions

Keywords

MRIBone marrow pathologies

Outcome Measures

Primary Outcomes (1)

  • Evaluation of the efficacy of MRI diffusion in differentiation between Various Vertebral bone marrow pathological lesions. .

    Primary (main): Establishing correlations between DWI findings and laboratory, clinical or histopathological results.

    Baseline

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

\- All adult patients with various vertebral bone marrow lesions.

You may qualify if:

  • All adult patients with vertebral lesions Clinically suspected or diagnosed by other modalities as X-ray or CT were included in the study.

You may not qualify if:

  • Patients with metallic prosthesis which are not MRI compatible .
  • patients with previous Vertebral surgery.
  • patients with Vertebral Congenital anomalies
  • Patients refused the examination.
  • Patients who suffer from claustrophobia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (5)

  • Leake RL, Mills MK, Hanrahan CJ. Spinal Marrow Imaging: Clues to Disease. Radiol Clin North Am. 2019 Mar;57(2):359-375. doi: 10.1016/j.rcl.2018.09.008. Epub 2018 Nov 17.

    PMID: 30709475BACKGROUND
  • Lin S, Ouyang T, Kanekar S. Imaging of Bone Marrow. Hematol Oncol Clin North Am. 2016 Aug;30(4):945-71. doi: 10.1016/j.hoc.2016.03.012.

    PMID: 27444005BACKGROUND
  • Dietrich O, Geith T, Reiser MF, Baur-Melnyk A. Diffusion imaging of the vertebral bone marrow. NMR Biomed. 2017 Mar;30(3). doi: 10.1002/nbm.3333. Epub 2015 Jun 26.

    PMID: 26114411BACKGROUND
  • Karampinos DC, Ruschke S, Dieckmeyer M, Diefenbach M, Franz D, Gersing AS, Krug R, Baum T. Quantitative MRI and spectroscopy of bone marrow. J Magn Reson Imaging. 2018 Feb;47(2):332-353. doi: 10.1002/jmri.25769. Epub 2017 Jun 1.

    PMID: 28570033BACKGROUND
  • Padhani AR, Koh DM. Diffusion MR imaging for monitoring of treatment response. Magn Reson Imaging Clin N Am. 2011 Feb;19(1):181-209. doi: 10.1016/j.mric.2010.10.004.

    PMID: 21129641BACKGROUND

MeSH Terms

Conditions

Bone Marrow Diseases

Condition Hierarchy (Ancestors)

Hematologic DiseasesHemic and Lymphatic Diseases

Study Officials

  • Eman A. Ahmed

    Professor

    STUDY DIRECTOR
  • Shimaa F. Gad

    Assistant professor

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 21, 2024

First Posted

November 25, 2024

Study Start

December 15, 2024

Primary Completion

December 1, 2025

Study Completion

January 1, 2026

Last Updated

November 29, 2024

Record last verified: 2024-11